{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:37:04Z","timestamp":1778949424240,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,10]]},"DOI":"10.1097\/qad.0b013e328362e874","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T12:44:18Z","timestamp":1368276258000},"page":"2291-2299","source":"Crossref","is-referenced-by-count":24,"title":["Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women"],"prefix":"10.1097","volume":"27","author":[{"given":"Todd H.","family":"Driver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen A.","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis C.","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony W.","family":"Butch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Anastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mardge H.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-16-20210130","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e32834884e6","article-title":"Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.","volume":"25","author":"Scherzer","year":"2011","journal-title":"AIDS"},{"key":"R3-16-20210130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/gerona\/glq228","article-title":"Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.","volume":"66","author":"Yarasheski","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R4-16-20210130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAI.0b013e3182832578","article-title":"Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults.","volume":"62","author":"Lee","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-16-20210130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbalip.2010.01.007","article-title":"HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.","volume":"1801","author":"Richmond","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R6-16-20210130","doi-asserted-by":"crossref","first-page":"E481","DOI":"10.1152\/ajpendo.00319.2002","article-title":"Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons.","volume":"284","author":"Barbieri","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R7-16-20210130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2044-5040-2-10","article-title":"Premature expression of a muscle fibrosis axis in chronic HIV infection.","volume":"2","author":"Kusko","year":"2012","journal-title":"Skelet Muscle"},{"key":"R8-16-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1523-1755.2002.00094.x","article-title":"Predictors of proteinuria and renal failure among women with HIV infection.","volume":"61","author":"Szczech","year":"2002","journal-title":"Kidney Int"},{"key":"R9-16-20210130","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1086\/424013","article-title":"Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy.","volume":"39","author":"Szczech","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R10-16-20210130","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/00002030-200411050-00009","article-title":"Factors associated with chronic renal failure in HIV-infected ambulatory patients.","volume":"18","author":"Krawczyk","year":"2004","journal-title":"AIDS"},{"key":"R11-16-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP61001","article-title":"Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients.","volume":"61","author":"Gupta","year":"2004","journal-title":"Clin Nephrol"},{"key":"R12-16-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00126334-200302010-00013","article-title":"Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.","volume":"32","author":"Gardner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-16-20210130","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1097\/01.ASN.0000138546.53152.A7","article-title":"Is there an epidemic of HIV Infection in the US ESRD program.","volume":"15","author":"Eggers","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R14-16-20210130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/QAD.0b013e3280d3587f","article-title":"Microalbuminuria in HIV infection.","volume":"21","author":"Szczech","year":"2007","journal-title":"AIDS"},{"key":"R15-16-20210130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection.","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"key":"R16-16-20210130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.109.898585","article-title":"Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.","volume":"121","author":"Choi","year":"2010","journal-title":"Circulation"},{"key":"R17-16-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/QAD.0b013e3283359253","article-title":"Kidney function and the risk of cardiovascular events in HIV-1-infected patients.","volume":"24","author":"George","year":"2010","journal-title":"AIDS"},{"key":"R18-16-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/QAI.0b013e3181cc1070","article-title":"Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.","volume":"55","author":"Wyatt","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-16-20210130","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2215\/CJN.02030408","article-title":"Screening for kidney diseases: older measures versus novel biomarkers.","volume":"3","author":"Wu","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-16-20210130","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function: measured and estimated glomerular filtration rate.","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"R21-16-20210130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1681\/ASN.2010050483","article-title":"Cystatin C identifies chronic kidney disease patients at higher risk for complications.","volume":"22","author":"Peralta","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R22-16-20210130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-142-7-200504050-00008","article-title":"Cystatin C concentration as a risk factor for heart failure in older adults.","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"R23-16-20210130","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons.","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"key":"R24-16-20210130","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"key":"R25-16-20210130","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/archinte.167.20.2213","article-title":"Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.","volume":"167","author":"Odden","year":"2007","journal-title":"Arch Intern Med"},{"key":"R26-16-20210130","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.ajkd.2010.05.019","article-title":"Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.","volume":"56","author":"Choi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R27-16-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":"The Womens Interagency HIV Study. WIHS Collaborative Study Group.","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"R28-16-20210130","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/CDLI.12.9.1013-1019.2005","article-title":"The Womens Interagency HIV Study: an observational cohort brings clinical sciences to the bench.","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R30-16-20210130","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.ajkd.2011.05.019","article-title":"Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values.","volume":"58","author":"Inker","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R31-16-20210130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"R32-16-20210130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/QAI.0b013e31826a6c4f","article-title":"Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.","volume":"61","author":"Inker","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-16-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"R35-16-20210130","first-page":"382","article-title":"Bayesian model averaging: a tutorial.","volume":"14","author":"Hoeting","year":"1999","journal-title":"Statistical Sci"},{"key":"R38-16-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"R39-16-20210130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"key":"R40-16-20210130","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1053\/j.ajkd.2008.01.027","article-title":"Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.","volume":"51","author":"Jones","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R41-16-20210130","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.ajkd.2011.10.050","article-title":"Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.","volume":"59","author":"Jotwani","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R42-16-20210130","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R43-16-20210130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1468-1293.2010.00855.x","article-title":"Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.","volume":"12","author":"Tordato","year":"2011","journal-title":"HIV Med"},{"key":"R44-16-20210130","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":"Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"},{"key":"R45-16-20210130","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1086\/523729","article-title":"Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.","volume":"45","author":"Choi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R46-16-20210130","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0b013e328356480d","article-title":"Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients.","volume":"26","author":"Praditpornsilpa","year":"2012","journal-title":"AIDS"},{"key":"R47-16-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.antiviral.2010.09.015","article-title":"Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort.","volume":"88","author":"Bonjoch","year":"2010","journal-title":"Antiviral Res"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e328362e874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:36:01Z","timestamp":1620970561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201309100-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,10]]},"references-count":42,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328362e874","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,10]]}}}